shared knowledge shared progress
Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessmentsLhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022
29 April 2022
10 February 2022
Nitrites in Excipients Data Sharing Consortium: Supporting Nitrosamine Risk AssessmentNitrite analysis of excipients is a new and analytically challenging area, with many organisations working quickly to determine the best practice and techniques to use.
The Nitrites in Excipients data sharing consortium was established in September 2020 and is part of Lhasa Limited's effort to support the global challenge of nitrosamine risk assessment.
22 February 2022
05 August 2021
08 April 2021
Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessmentsLhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022
Is expert review an essential step when assessing mutagenic potential of drug impurities?A provision for the application of ‘expert knowledge’ is mentioned within the ICH M7 guideline. However, as (Q)SAR models continue to be updated and their predictive performance and structural coverage improves, this raises the question of whether expert review is still necessary…
05 May 2022
May 2022Nitrites in Excipients
May 2022Derek Nexus
April 2022Kaptis
Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessmentsLhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022
03 May 2022
29 April 2022
Is expert review an essential step when assessing mutagenic potential of drug impurities?A provision for the application of ‘expert knowledge’ is mentioned within the ICH M7 guideline. However, as (Q)SAR models continue to be updated and their predictive performance and structural coverage improves, this raises the question of whether expert review is still necessary…
05 May 2022
04 April 2022
02 March 2022
Teasdale A;This presentation was given by Dr Andrew Teasdale at the 2019 Pharmaceutical Industry and Regulators Symposium, in Brazil.
© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).
Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.
